Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Serine/threonine-protein kinase B-raf | ||
Ligand | BDBM50026212 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_685663 (CHEMBL1285565) | ||
IC50 | <0.100000±n/a nM | ||
Citation | Wang, X; Berger, DM; Salaski, EJ; Torres, N; Dutia, M; Hanna, C; Hu, Y; Levin, JI; Powell, D; Wojciechowicz, D; Collins, K; Frommer, E; Lucas, J Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity. J Med Chem53:7874-8 (2010) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Serine/threonine-protein kinase B-raf | |||
Name: | Serine/threonine-protein kinase B-raf | ||
Synonyms: | B-RAF | B-Raf Protein Kinase | B-Raf proto-oncogene serine/threonine-protein kinase | BRAF | BRAF1 | BRAF_HUMAN | RAFB1 | p94 | v-Raf murine sarcoma viral oncogene homolog B1 | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 84446.00 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P15056 | ||
Residue: | 766 | ||
Sequence: |
| ||
BDBM50026212 | |||
n/a | |||
Name | BDBM50026212 | ||
Synonyms: | CHEMBL1276185 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H24F2N8 | ||
Mol. Mass. | 534.562 | ||
SMILES | [H][C@]12CN(c3ccc(c(F)c3)-c3ccnc4c(c(nn34)-c3ccncc3)-c3ccc(F)c4[nH]ncc34)[C@]([H])(CN1C)C2 |r,wU:36.42,1.0,(5.96,-12.33,;4.87,-13.43,;4.88,-14.97,;3.54,-15.75,;3.55,-17.28,;4.89,-18.05,;4.89,-19.59,;3.56,-20.36,;2.23,-19.6,;.9,-20.38,;2.22,-18.06,;3.57,-21.9,;2.24,-22.67,;2.24,-24.21,;3.57,-24.98,;4.91,-24.21,;6.38,-24.69,;7.29,-23.44,;6.38,-22.18,;4.91,-22.66,;8.83,-23.43,;9.6,-24.77,;11.14,-24.77,;11.91,-23.43,;11.13,-22.09,;9.6,-22.1,;6.86,-26.15,;8.36,-26.47,;8.84,-27.93,;7.81,-29.09,;8.29,-30.55,;6.3,-28.76,;5.05,-29.66,;3.81,-28.75,;4.3,-27.29,;5.83,-27.3,;2.21,-14.99,;.66,-14.98,;2.2,-13.45,;3.53,-12.67,;3.53,-11.12,;3.29,-13.89,)| | ||
Structure |